Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study by Raffi, Francois, Prof, Rachlis, Anita, Prof, Stellbrink, Hans-Jürgen, Prof, Hardy, W David, MD, Torti, Carlo, MD, Orkin, Chloe, MD, Bloch, Mark, MD, Podzamczer, Daniel, MD, Pokrovsky, Vadim, Prof, Pulido, Federico, MD, Almond, Steve, MMath, Margolis, David, MD, Brennan, Clare, DPT, Min, Sherene, MD

Get full text

A randomized pilot study of tenofovir/emtricitabine (TDF/FTC) + boosted atazanavir (ATV/r) vs. raltegravir (RAL BID) + ATV/r vs. RAL BID + ATV BID by Cohen, C, Green, J, Olivet, H, Khanlou, H, Burman, W, Corales, R, Pierone, G, DeJesus, E, Vanig, T, Tribble, M, Sweet, D, Appelbaum, J, Garb, J

Get full text

Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in HIV-infected, Virologically Suppressed Black and Non-Blacks Adults Through Week 96: Subgroup Analy... by Flamm, Jason A, Vanig, Thanes, Gathe, Joseph, Kinder, Clifford, Para, Michael, Rashbaum, Bruce, Segal-Maurer, Sorana, Shamblaw, David, Wohlfeiler, Michael, Young, Benjamin, Zurawski, Christine, Rhee, Martin S

Get full text

Recommended guidelines for uniform reporting of data from drowning: the “Utstein style” by Idris, A.H., Berg, R.A., Bierens, J., Bossaert, L., Branche, C.M., Gabrielli, A., Graves, S.A., Handley, A.J., Hoelle, R., Morley, P.T., Papa, L., Pepe, P.E., Quan, L., Szpilman, D., Wigginton, J.G., Modell, J.H.

Get full text

Universal Definition of Myocardial Infarction by Thygesen, Kristian, Alpert, Joseph S., White, Harvey D.

Get full text